Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Antiemetics are therapeutic agents that are effective against nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress and food poisoning.
These drugs are often used to treat the side effects of other medications including opioid analgesics, Chemotherapy and general anesthetics.
The global Antiemetics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antiemetics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antiemetics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antiemetics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antiemetics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
GlaxoSmithKline
Merck
Sanofi Aventis
Bristol Myers Squibb
Eli Lilly
Pfizer
Astellas
Johnson & Johnson
Baxter
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
5-HT3 receptor antagonists
Dopamine antagonists
NK1 receptor antagonist
Antihistamines (H1 histamine receptor antagonists)
Cannabinoids
Benzodiazepines
Anticholinergics
Steroids
Others
Segment by Application
Chemotherapy
Motion sickness
Gastroenteritis
General anesthetics
Opioid analgesics
Dizziness
Pregnancy
Food poisoning
Emotional stress
Others
These drugs are often used to treat the side effects of other medications including opioid analgesics, Chemotherapy and general anesthetics.
The global Antiemetics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antiemetics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antiemetics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antiemetics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antiemetics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
GlaxoSmithKline
Merck
Sanofi Aventis
Bristol Myers Squibb
Eli Lilly
Pfizer
Astellas
Johnson & Johnson
Baxter
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
5-HT3 receptor antagonists
Dopamine antagonists
NK1 receptor antagonist
Antihistamines (H1 histamine receptor antagonists)
Cannabinoids
Benzodiazepines
Anticholinergics
Steroids
Others
Segment by Application
Chemotherapy
Motion sickness
Gastroenteritis
General anesthetics
Opioid analgesics
Dizziness
Pregnancy
Food poisoning
Emotional stress
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
